The FDA (Food and Drug Administration) and the CDC (Centers for Disease Control and Dissemination) are recommending that Johnson & Johnson’s vaccine be resumed, removing all restrictions, The New York Times reported.
The decision of the regulators was made on the basis of the recommendations of the expert council. At a press conference on Friday, Janet Woodcock, acting director of the FDA, announced:
“We have decided to reactivate this vaccine following a vote by the Centers for Disease Control and Prevention panel of experts.”
Rochelle Walensky, head of the federal Centers for Disease Control and Prevention, said vaccinations with the drug could resume immediately on Saturday morning.
The suspension of the Johnson & Johnson vaccine was announced on April 13 by the Centers for Disease Control and Prevention and the Food and Drug Administration of the US Department of Health and Human Services. Potential side effects after vaccination were the cause. In the United States, 6.8 million people have been vaccinated with Johnson & Johnson. In 15 vaccinated women, from 18 to 48 years old, thrombi was found 6-13 days after vaccination, three of them died.